Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Capital Expenditures (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Capital Expenditures data on record, last reported at $105000.0 in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 98.11% year-over-year to $105000.0; the TTM value through Dec 2025 reached $315000.0, up 152.0%, while the annual FY2025 figure was $315000.0, 152.0% up from the prior year.
  • Capital Expenditures reached $105000.0 in Q4 2025 per PLSE's latest filing, up from $62000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $279000.0 in Q1 2022 and bottomed at $16000.0 in Q2 2023.
  • Average Capital Expenditures over 5 years is $73631.6, with a median of $53000.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: plummeted 86.02% in 2023, then soared 543.75% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $134000.0 in 2021, then plummeted by 69.4% to $41000.0 in 2022, then rose by 4.88% to $43000.0 in 2023, then grew by 23.26% to $53000.0 in 2024, then surged by 98.11% to $105000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $105000.0 in Q4 2025, $62000.0 in Q3 2025, and $103000.0 in Q2 2025.